CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-&#945; and TRAIL in Pancreatic Tumor Cells.

CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells.

Rashid, Khalid; Röder, Christian; Goumas, Freya; Egberts, Jan-Hendrik; Kalthoff, Holger.

Afiliación

Rashid K; Institute for Experimental Cancer Research, University Medical Centre Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, University Medical Centre Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Goumas F; Department of General, Visceral-, Thoracic-, Transplantation- and Paediatric Surgery, University Medical Centre Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Egberts JH; Department of General, Visceral-, Thoracic-, Transplantation- and Paediatric Surgery, University Medical Centre Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Kalthoff H; Department of Visceral Surgery, Israelitisches Krankenhaus, 22297 Hamburg, Germany.

Cancers (Basel) ; 13(21)2021 Oct 30.

Article en En | MEDLINE | ID: mdl-34771621